Gene · 3045
HBD: hemoglobin subunit delta
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. HBD: hemoglobin subunit delta. Genes, record 3045. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/3045
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P02042 | Hemoglobin subunit delta | 147 | 2 | Ensembl, GeneID, HGNC |
Source UniProt
Patents73
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 48889 | P02042 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 3984 | P02042 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 24817 | P02042 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 1914 | P02042 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 1914 | P02042 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 3984 | P02042 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 24817 | P02042 | Espacenet |
| US 11834668 B2 | 2023-12-05 | 15 | P02042 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 37719 | P02042 | Espacenet |
| US 11400027 B2 | 2022-08-02 | 10 | P02042 | Espacenet |
1 to 10 of 73
See all 73 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants376
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | HBD papers | Newest fiscal year |
|---|---|---|---|
| P20GM109021 | The Delaware Comprehensive Sickle Cell Research Center | 2 | 2025 |
| P30CA023108 | Cancer Center Support Grant | 2 | 2025 |
| P30DK026743 | UCSF Liver Center | 2 | 2025 |
| R01HL119479 | Regulation of Hemoglobin Switching | 2 | 2025 |
| T32AI007363 | Immunobiology of Myeloid and Lymphoid Cells | 2 | 2025 |
| U54DK106829 | Stem Cell and Transplantation Biology | 2 | 2025 |
| ZIAHL002338 | Genetic Modification and Novel Cell Therapies in Non-Human Primate Hematopoietic Cells | 2 | 2025 |
| P01HL158507 | Scientific innovation for personalized severe asthma management | 1 | 2025 |
| P20GM103446 | Delaware INBRE | 1 | 2025 |
| P30AG066468 | Alzheimer Disease Research Center | 1 | 2025 |
1 to 10 of 376Source NIH's project files
See all 376 nih grantsPapers808
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Microcytic Anemia with Low HbA2 and Normal HbA: Two Cases of Rare Thalassemia. | Hemoglobin | 2026 | 42655983 | PubTator, text mining | PubMed |
| Genetic Analysis of Two Patients with Compound Thalassemia Presenting with Elevated HbF and Normal HbA2 Levels. | Hemoglobin | 2026 | 42509210 | PubTator, text mining | PubMed |
Short-term maternal outcomes after intraoperative administration of prophylactic oxytocin during cesarean sections: a retrospective cohort study with a comparison of different administration protocols. | Arch Gynecol Obstet | 2026 | 41902958 | PubTator, text mining | PubMed |
| A novel HBD gene mutation associated with normal-range hb A2 in β-thalassemia carriers. | Ann Hematol | 2026 | 41765964 | PubTator, text mining | PubMed |
| The Mystery of the Hidden Trace: Emerging Genetic Approaches to Improve Body Fluid Identification. | Genes (Basel) | 2026 | 41751530 | PubTator, text mining | PubMed |
| The impact of the expression signatures of LncRNAs HBBP1 and XIST on the diagnostic significance of patients with β-Thalassemia. | Ann Hematol | 2026 | 41634383 | PubTator, text mining | PubMed |
| Two Novel δ-Globin Chain Variants Identified in the Chinese Population. | Hemoglobin | 2026 | 41508683 | PubTator, text mining | PubMed |
| IFN-γ increases δ-globin gene expression through activation of the JAK/STAT pathway in erythroid cells. | Blood | 2026 | 41284617 | PubTator, text mining | PubMed |
| From anonymity to stardom: history of nontuberculous mycobacterial disease in humans. | Front Cell Infect Microbiol | 2025 | 41808770 | PubTator, text mining | PubMed |
| The Masked Thalassemia: A Rare Case of a Patient with Normal HbA2 Levels, β-Thalassemia Pathogenic Variant (CD39 C>T), and a Novel δ-Globin Gene Deletion. | Appl Clin Genet | 2025 | 41255956 | PubTator, text mining | PubMed |
1 to 10 of 808
See all 808 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/3045
GET https://conductscience.org/api/genes/v1/3045/patents?page=2